Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT00549848
Title Total Therapy Study XVI for Newly Diagnosed Patients With Acute Lymphoblastic Leukemia
Recruitment Active, not recruiting
Gender both
Phase Phase III
Variant Requirements No
Sponsors St. Jude Children's Research Hospital
Indications

acute lymphoblastic leukemia

Therapies

Daunorubicin + Pegaspargase + Vincristine Sulfate

Cytarabine

Mercaptopurine

Thioguanine

Clofarabine + Cyclophosphamide + Etoposide

Methotrexate

Dasatinib

Doxorubicin

Dexamethasone

Age Groups: child
Covered Countries USA


No variant requirements are available.